Dr. David William Werner, PSY. D Psychologist - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 10 Pearl St, Dedham, MA 02026 Phone: 781-329-1159 Fax: 781-329-1183 |
Virginia D Reiber, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 601 High St, Suite 204, Dedham, MA 02026 Phone: 781-352-0930 Fax: 781-329-1183 |
Martha Hardy Lamb Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 7 Commonwealth Ave, Dedham, MA 02026 Phone: 781-856-2433 |
Dr. Sharon Veronique Kreder, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 20 Eastbrook Rd, Dedham, MA 02026 Phone: 781-329-9365 Fax: 781-302-4635 |
Dr. Elizabeth Hayes Wilson, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 7 Whitcomb Rd, Dedham, MA 02026 Phone: 508-472-3116 |
Dr. Janette Howard Harris, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 118 Allied Dr, Dedham, MA 02026 Phone: 781-449-8545 Fax: 781-449-8544 |
Dr. Lindsay Kurahara, PSYD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 30 Eastbrook Rd Ste 101, Dedham, MA 02026 Phone: 857-293-5020 Fax: 857-226-8772 |
News Archive
Despite previous research suggesting that older adults are more distractible, new research shows they are no more distractible than younger adults when asked to focus their attention on their sense of sight or sound, or when asked to switch their attention from one sense to the other.
Alzheimer's disease - also called dementia - where memory and cognitive functions gradually decline due to deformation and death of neurons, and Parkinson's disease that causes tremors in hands and arms impeding normal movement are major neurodegenerative diseases.
ELPA today launched a new call to action report ‘Time to DeLiver: Getting a Grip on HE' at the European Parliament in Brussels. This is the first report from Europe to highlight the significant burden of hepatic encephalopathy on patients, their carers, families and society.
Rowan University and Bamboo Therapeutics, Inc. have entered into an asset transfer agreement to commercialize a novel gene therapy for the treatment of Canavan disease. A rare but devastating neurological disease that tragically takes a child's life by age 10, Canavan disease is one of the most common and complex degenerative cerebral diseases in infants.
› Verified 3 days ago